Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination [Erratum]

Contreras-Salinas H, Barajas-Hernández M, Baiza-Durán LM, Vázquez-Álvarez AO, Bautista-Castro MA, Rodríguez-Herrera LY. Clin Ophthalmol. 2021;15:583-590. On page 587, Table 3 was distorted during the correction stage and published in error. The correct Table 3is shown in Download Article. Table 3 AD...

Full description

Saved in:
Bibliographic Details
Published inClinical ophthalmology (Auckland, N.Z.) Vol. 16; pp. 245 - 246
Main Authors Contreras-Salinas, Homero, Barajas-Hernández, Mariana, Baiza-Durán, Leopoldo Martín, Vázquez-Álvarez, Alan Omar, Bautista-Castro, Manuel Alejandro, Rodríguez-Herrera, Lourdes Yolotzin
Format Journal Article
LanguageEnglish
Published Auckland Dove Medical Press Limited 28.02.2022
Taylor & Francis Ltd
Dove
Dove Medical Press
Subjects
active pharmacovigilance
adverse drug reactions
Erratum
glaucoma
surveillance
timolol/brimonidine/dorzolamide
Online AccessGet full text

Cover

More Information
Summary:Contreras-Salinas H, Barajas-Hernández M, Baiza-Durán LM, Vázquez-Álvarez AO, Bautista-Castro MA, Rodríguez-Herrera LY. Clin Ophthalmol. 2021;15:583-590. On page 587, Table 3 was distorted during the correction stage and published in error. The correct Table 3is shown in Download Article. Table 3 ADRs of TBD vs Reported by Individual Active Ingredient This error was introduced by the typesetting team during the editing process and was not picked up before publication. Read the original article
ISSN:1177-5483
1177-5467
1177-5483
DOI:10.2147/OPTH.S359723